Comparative efficacy and safety of NALIRIFOX versus other first-line chemotherapy regimens in metastatic pancreatic ductal adenocarcinoma: a retrospective study.

Ther Adv Med Oncol · 2026 · PMC13199695 · PMID 42199489

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

did not reach statistical significancep = 0.17not close (p > 0.1)

Results showed that differences in PFS and OS between patients with tumors in different locations did not reach statistical significance (PFS: p = 0.17; OS: p = 0.102).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.